158 related articles for article (PubMed ID: 21835526)
41. Pharmaceutical companies as a source of health information: a pilot study of the effects of source, web site interactivity, and involvement.
Kim H
Health Mark Q; 2011 Jan; 28(1):57-85. PubMed ID: 21347942
[TBL] [Abstract][Full Text] [Related]
42. The message development tool: a case for effective operationalization of messaging in social marketing practice.
Mattson M; Basu A
Health Mark Q; 2010 Jul; 27(3):275-90. PubMed ID: 20706895
[TBL] [Abstract][Full Text] [Related]
43. Pharmaceutical sales reps: value beyond samples.
Flewell MN
Adv Nurse Pract; 2006 Jul; 14(7):18. PubMed ID: 16977890
[No Abstract] [Full Text] [Related]
44. The promise of pharmacogenetics: assessing the prospects for disease and patient stratification.
Smart A; Martin P
Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):583-601. PubMed ID: 16980196
[TBL] [Abstract][Full Text] [Related]
45. Diagnosis of premenstrual disorders.
Futterman LA; Rapkin AJ
J Reprod Med; 2006 Apr; 51(4 Suppl):349-58. PubMed ID: 16734318
[TBL] [Abstract][Full Text] [Related]
46. Ethics in the marketing of medical services.
Latham SR
Mt Sinai J Med; 2004 Sep; 71(4):243-50. PubMed ID: 15365590
[TBL] [Abstract][Full Text] [Related]
47. Jordanian pharmaceutical companies: are their marketing efforts paying off?
Al-Shaikh MS; Torres IM; Zuniga MA; Ghunaim A
Health Mark Q; 2011 Apr; 28(2):174-89. PubMed ID: 21590563
[TBL] [Abstract][Full Text] [Related]
48. Establishing the diagnostic validity of premenstrual dysphoric disorder using rasch analysis.
Gehlert S; Chang CH; Hartlage S
J Outcome Meas; 1997; 1(1):2-18. PubMed ID: 9661712
[TBL] [Abstract][Full Text] [Related]
49. Patient awareness and concern regarding pharmaceutical manufacturer interactions with doctors.
Edwards D; Ballantyne A
Intern Med J; 2009 Mar; 39(3):191-6. PubMed ID: 19383067
[TBL] [Abstract][Full Text] [Related]
50. Pharmaceutical direct-to-consumer advertising and US Hispanic patient-consumers.
Barker KK; Vasquez Guzman CE
Sociol Health Illn; 2015 Nov; 37(8):1337-51. PubMed ID: 26235537
[TBL] [Abstract][Full Text] [Related]
51. Neuromarketing techniques in pharmaceutical drugs advertising. A discussion and agenda for future research.
Orzan G; Zara IA; Purcarea VL
J Med Life; 2012 Dec; 5(4):428-32. PubMed ID: 23346245
[TBL] [Abstract][Full Text] [Related]
52. A national survey on the effect of pharmaceutical promotion on medical students.
Vainiomäki M; Helve O; Vuorenkoski L
Med Teach; 2004 Nov; 26(7):630-4. PubMed ID: 15763854
[TBL] [Abstract][Full Text] [Related]
53. The fine line between education and marketing.
Proj Inf Perspect; 1999 Sep; (28):1-3. PubMed ID: 11367352
[TBL] [Abstract][Full Text] [Related]
54. The undiscovered Argentine pharmaceutical market.
Felix PF; Thomas RK; Pol LG
Mark Health Serv; 2001; 21(4):12-6. PubMed ID: 11763647
[TBL] [Abstract][Full Text] [Related]
55. Bringing customers into the boardroom.
McGovern GJ; Court D; Quelch JA; Crawford B
Harv Bus Rev; 2004 Nov; 82(11):70-80, 148. PubMed ID: 15559447
[TBL] [Abstract][Full Text] [Related]
56. Disease mongering in psychiatry: fact or fiction?
Saddichha S
JNMA J Nepal Med Assoc; 2010; 50(180):320-7. PubMed ID: 22049901
[TBL] [Abstract][Full Text] [Related]
57. High levels of confusion for cholesterol awareness campaigns.
Hall DV
Med J Aust; 2008 Sep; 189(6):326-8; discussion 328-9. PubMed ID: 18803537
[TBL] [Abstract][Full Text] [Related]
58. The next front.
Fetter MS
Medsurg Nurs; 1998 Aug; 7(4):186-7. PubMed ID: 9782887
[No Abstract] [Full Text] [Related]
59. For pharmaceutical companies, a data warehouse can be just what the doctor ordered.
Desai A
Health Manag Technol; 1999 Mar; 20(2):20-2. PubMed ID: 10346471
[No Abstract] [Full Text] [Related]
60. Exposure of medical students to pharmaceutical marketing in primary care settings: frequent and influential.
Sarikaya O; Civaner M; Vatansever K
Adv Health Sci Educ Theory Pract; 2009 Dec; 14(5):713-24. PubMed ID: 19184498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
